Core Insights - MediPharm Labs Corp. has launched a new Shake & Puff CBN THC Nighttime Inhaler in Canada, expanding its CBN oil product portfolio and building on the success of its earlier THC Inhaler [1][2] Product Overview - The new metered dose inhaler provides a precise formulation of minor cannabinoid CBN and THC in a smoke-free format, designed for nighttime use with a fast onset experience [2][4] - The inhaler format ensures precision and repeatability, offering a familiar and discreet option similar to asthma inhalers, with no lingering smell or by-products [4][11] Strategic Positioning - The launch is part of MediPharm's strategy to deliver innovative, pharma-grade cannabinoid products globally, positioning the company to lead in smoke-free, precisely dosed formats that align with consumer wellness trends and medical needs [2][5] - The company plans to expand its inhaler offerings with additional CBD and CBG options in the future, continuing to lead in pharma-grade cannabinoid innovation [5] Company Background - MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates and advanced derivative products, operating in a GMP certified facility [6] - The company received a Pharmaceutical Drug Establishment License from Health Canada in 2021, becoming the only North American company with a commercial-scale GMP License for the extraction of multiple natural cannabinoids [7] - In 2023, MediPharm acquired VIVO Cannabis Inc., enhancing its reach to medical patients in Canada and expanding into international markets [8]